ACCME Accreditation Statement

This activity (“American Society for Investigative Pathology [ASIP] 2018 Annual Meeting”) has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Society for Clinical Pathology (ASCP) and the American Society for Investigative Pathology (ASIP) The ASCP is accredited by the ACCME to provide continuing medical education for physicians.

The ASCP designates this “live” educational activity (ASIP 2018 Annual Meeting) for a maximum of 30.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Educational Objective/Target Audience:

The objective of the ASIP 2018 Annual Meeting is to increase basic and applied pathology knowledge, focusing on pathogenesis of disease. The ASIP 2018 Annual Meeting is designed to meet the participants' education needs in the physician competency area of Medical Knowledge, as defined by the Accreditation Council for Graduate Medical Education (ACGME) and the American Board of Medical Specialties (ABMS), and to support participants' lifelong learning towards a goal of promoting patient safety and improving patient care and is specifically targeted to graduate and medical students, pathology residents, post-doctoral fellows, research scientists, clinical practitioners, laboratory professionals, and medical education professionals.

At the completion of the ASIP 2018 Annual Meeting, participants should be able to:

• discuss the research underway and/or the current topics relevant to their areas of interest in pathology;
• demonstrate a gained level of knowledge of the methods and techniques being used by researchers and practitioners in the field;
• utilize information and data that lead to improvements in human health.

Sessions Eligible for CME:

Please note that the only Society educational component of Experimental Biology 2018 that is eligible for CME credit is the ASIP 2018 Annual Meeting.

This ASIP 2018 Annual Meeting CME Workbook includes a consolidated list of ASIP scientific sessions that are eligible for AMA PRA Category 1 Credit(s)™.  The ASIP 2018 Annual Meeting CME Workbook will be available online on the ASIP Meeting website (http://asip18.asip.org/cme/) beginning April 9, 2018 and onsite in the ASIP Office and the Experimental Biology Meeting Management Office located in the San Diego Convention Center. In addition, signage outside of the ASIP meeting rooms will designate those educational sessions that are eligible for AMA PRA Category 1 Credit(s)™ as indicated by the word “CME.”

Please note that some ASIP scientific sessions are not eligible for AMA PRA Category 1 Credit(s)™ because faculty disclosures of financial relationships with commercial interests could not be resolved or managed. Please also be aware that visiting exhibits and posters in the exhibit hall is not an approved continuing medical education activity because of ACCME standards that are designed to prevent commercial bias.

How to Apply for CME Credit: 

CME Application Forms can be found on the ASIP Meeting website (http://asip18.asip.org/cme/) beginning April 9, 2018. Applications for CME credit must be submitted online no later than June 1, 2018. You will receive your CME certificate within two weeks of successful submission of your online application. If you have questions concerning your CME application (or do not receive your certificate within the timeframe explained above), contact the ASIP Education Office by phone (240) 283-9712, email cme@asip.org or write to ASIP Education Office, 1801 Rockville Pike, Suite 350, Rockville, MD 20852.

CME Application Fees:

• ASIP members in good standing: there is NO FEE to apply for CME for the ASIP 2018 Annual Meeting
• Non-ASIP members: there is a $100 application fee, payable upon submission of the online CME application.

Disclosure of Financial Relationships and Resolution of Conflicts of Interest:

In order to ensure balance, independence, objectivity and scientific rigor in all its educational activities, and in accordance with ACCME Standards, the ASCP requires that all individuals in a position to influence and/or control the content of ASCP CME activities disclose to the ASCP and subsequently to learners whether they do or do not have any relevant financial relationships with proprietary entities producing health care goods or services that are discussed in CME activities. Faculty are asked to use generic names in any discussion of therapeutic options, to base patient care recommendations on scientific evidence and to base information regarding commercial products/services on scientific methods generally accepted by the medical community. All ASCP CME activities are evaluated by participants for the presence of any commercial bias and thus input is used to subsequent CME planning decisions. The primary purpose of this "live" CME activity is educational and the comments, opinions, and/or recommendations expressed by the faculty or authors are their own and not those of ASCP or ASIP.

The Planning Committee members and staff of this CME activity have been asked to disclose any relationships that could be perceived by some as a real or apparent conflict of interest. The staff and Planning Committee members have no relevant financial relationships with commercial interests to disclose.

The following members of the Planning Committee and staff have no relevant financial relationships with commercial interests to disclose:

All invited faculty of CME-designated sessions have been asked to disclose any relationships that, in the context of their presentation, could be perceived by some as a real or apparent conflict of interest.  All faculty with disclosed relationships have affirmed that they do not consider these relationships will influence their presentation.  The disclosures have been reviewed and conflicts of interest resolved or managed.

Faculty Disclosures:

The following faculty have no relevant financial relationships with commercial interests to disclose: